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Time-Resolved Pharmacological 
Studies using Automated, On-
line Monitoring of Five Parallel 
Suspension Cultures
Ala A. Alhusban1,2,4, Michael C. Breadmore1, Nuri Gueven3 & Rosanne M. Guijt  2,5
Early stage pharmacological studies rely on in vitro methodologies for screening and testing 
compounds. Conventional assays based on endpoint measurements provide limited information 
because the lack in temporal resolution may not determine the pharmacological effect at its maximum. 
We developed an on-line, automated system for near real-time monitoring of extracellular content 
from five parallel suspension cultures, combining cell density measurements with a high-resolution 
separations every 12 minutes for 4 days. Selector and switching valves provide the fluidic control 
required to sample from one culture during the analysis of the previous sample from another culture, a 
time-saving measure that is fundamental to the throughput of the presented system. The system was 
applied to study the metabolic effects of the drugs rotenone, β-lapachone and clioquinol using lactate 
as metabolic indicator. For each drug, 96 assays were executed on the extracellular matrix at three 
concentrations with two controls in parallel, consuming only 5.78 mL of media from each culture over 
four days, less than 60 μL per analysis. The automated system provides high sample throughput, good 
temporal resolution and low sample consumption combined with a rugged analytical method with 
adequate sensitivity, providing a promising new platform for pharmacological and biotechnological 
studies.
Regulatory and ethical constraints on performing experiments on laboratory animals have directed pharmaco-
logical and toxicological studies towards cell-based based testing1. Cell culture experiments can be conducted 
with high throughput on a wide variety of cell types, with data typically derived as an end-point measurement 
using a plate reader. Whilst this is satisfactory for screening purposes, insight in the changes in (metabolic) bio-
markers over time would provide a more profound insight in the pharmacology of the compound. To enable 
this, changes in nutrient, substrate and/or metabolite concentration should be determined in an automated, low 
maintenance manner over short intervals and correlated with cell viability. The sample consumption of such an 
analytical system over the duration of the cell culture experiment should be minimal, and the sterility of the cell 
culture should not be compromised. Current technologies available for chemical monitoring fail to meet the 
combination of these requirements. Sensors have good sensitivity and selectivity, but are through their specificity 
restricted to one analyte of interest2 and the signal is prone to drift and requires regular calibration. To simultane-
ously analyze a range of analytes, and resolve these from interferences from the media, high-resolution analytical 
techniques are required. Spectroscopic techniques, for example using UV4, FTIR5 or RAMAN spectroscopy6, 7, 
can provide detailed chemical information, often without the need to take a physical sample, but despite advances 
in the interpretation of spectra, resolving complex analyte sets with similar functional groups remains challeng-
ing. Additional, complex chemometric models need to be established and maintained through regular training 
sets to account for minor changes in the monitored process. Mass spectrometry can be used to analyze cell culture 
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media, but the extensive sample clean-up often restricts its use for automated monitoring8. Chromatographic 
separations require extensive sample pre-treatment and each analysis takes >10 minutes, making it less suitable 
for a high throughput automated monitoring3. Recently, direct paper spray MS was demonstrated using a dialysis 
probe for monitoring extracellular glucose in adherent cell culture for 60 min, with quantitative analysis between 
0.1 and 8 g/L glucose enabled through the addition of an internal standard9. The Zamboni group introduced 
monitoring of changes to the metabolome by direct MS of samples containing whole bacteria, yeast and mam-
malian cells10. For the quantitative analysis of complex analyte sets, however, a high-resolution separation may be 
required. Capillary Electrophoresis (CE) is a powerful and fast separation technique capable of dealing with small 
sample volumes11, and has been employed in bioprocess monitoring for broad range of analytes12. For example, 
Sandlin et al. employed a microfluidic CE system for in vivo bioprocess monitoring of extracellular amino acids 
through on-line coupling of the chip to a microdialysis probe13. Using a microfluidic perfusion approach, the 
secretion of glucagon from pancreatic islets of Langerhans was monitored online using an electrophoretic hetero-
geneous immunoassay14. Our group presented a sampling method for the analysis of target analytes present in the 
cell-free media from adhesion culture by Sequential Injection Capillary Electrophoresis (SI-CE) for monitoring 
lactate production15. Suspension cultures are more commonly used in cell culture and biotechnology. Turkia et al. 
developed a flow-through interface for a commercial CE instrument, capable of obtaining a cell-free sample from 
a suspension culture by on-line filtration before analysis by CE. This system was used for monitoring extracellular 
organic acids over several days16. We recently presented a sampling method for the online analysis of lactate, glu-
cose, glutamine, and leucine/isoleucine in extracellular extracts obtained on-line from suspension cultures. This 
system was capable of monitoring a suspension culture of human T lymphocytes every 30 minutes over 4 days17.
Here, we present a system capable of monitoring five parallel cultures, enabling for pharmacological assays to 
be conducted under identical culturing conditions at several different concentrations, as illustrated in Fig. 1. To 
allow for monitoring parallel culture flasks, an automated fluidic system was developed that enabled switching 
between culture flasks for sampling. Fundamental changes to the automated liquid handling enabled increased 
throughput by sampling and cell density measurement during the CE separation of the previous sample. The sys-
tem provided an automated, high resolution separation and cell density measurement of human T lymphocytes 
every 12 minutes over 4 days, giving a data point an hour from each of 5 parallel culture flasks using only 60 μL 
of sample per analysis. To demonstrate the applicably of the system for pharmacological studies, three different 
pharmaceutical compounds (rotenone, clioquinol and β-lapachone) were selected based on their potential effect 
on lactate production and screened at three concentrations in parallel with two control experiments. Providing 
time-resolved dose response data, this fully automated and flexible system can provide a new perspective to the 
study of biochemical and metabolic effects in cell-based pharmacological assays. Importantly, the cell density 
measurements allow for normalizing the data and hence for the delineation of pharmacological and toxic effects.
Results and Discussion
Pharmacological studies are typically conducted at different drug concentrations and include one or two blanks. 
As biological systems are dynamic, one of the ways to minimize biological variability is to use multiple parallel 
flasks from the same starting culture to allow for culturing under identical conditions. To access time-resolved 
analytical data, each individual culture flask needs to be monitored individually. Because of the excessive infra-
structure required to have separate analytical systems operating in parallel, we developed an automated, on-line 
sampling method that enabled the use of a single analytical system for monitoring five parallel cultures. The 
separations were conducted by CE combined with sample injection using a sequential injection system. We pre-
viously demonstrated SI-CE to be capable of automated and rapid high-resolution separations of small sample 
volumes18, 19. Our previous systems were able to monitor a single adhesion15 or suspension culture17. The system 
presented here enables simultaneous monitoring of five parallel cultures. The new fluidics here use the fluidic 
isolation provided by the switching valve to conduct the sampling, cell density measurement and cell removal 
during the electrophoretic separation of the previous sample. Compared with our previous work, this decreased 
the run-to-run time from 22.5 min to 12 min (Table 1), which means that when monitoring 5 parallel cultures, a 
data point per hour can be obtained for each individual culture.
Figure 1. Schematic diagram of the experimental setup. Sample is sequentionally withdrawn from one of the 
five culture flasks, controlled by the selector valve. A carrier (5% methanol) is used to rinse to prevent cross 
contamination between samples. Digital imaging for cell density measurement is done using automated image 
analysis. The sample is then transported to a H-filter, where analytes are extracted into a cell-free solution, 
which is analysed by SI-CE with C4D. Fluidic isolation provided by the six port valve allows cell density 
measurement and extraction during the CE separation of the previous sample. With a run time of 12 minutes 
each flask is sampled once an hour.
www.nature.com/scientificreports/
3SCientiFiC REPORTS | 7: 10337  | DOI:10.1038/s41598-017-10472-1
The time-based concentration profile of a biomarker can provide insight in the effect of the administered 
drugs on the cells. To illustrate the potential of the system, extracellular lactate was selected as metabolic bio-
marker. Since different cell culture media contain a different range of compounds including amino acids, sugars, 
proteins, vitamins, organic and inorganic ions, the separation method developed for monitoring lactate pro-
duced by Human embryonic kidney cells (HEK293) in Dulbeccos Modified Eagles Medium (DMEM)15 had to be 
re-optimized to resolve lactate from interfering anions in the RPMI-1640 Medium used for culturing the human 
T lymphocyte cell line used here. BGE pH and concentration, PEI concentration, capillary coating, I.D. and 
length were all examined and optimized for stable performance over at least four days. The optimized conditions 
were as follows: 80 cm × 50 µm I.D. (10 cm to detector) fused silica capillary coated with polyelectrolytes HDMB/
PSS/HDMB in combination with a BGE containing, 35 mM Tris/35 mM CHES at pH 8.9 with 0.025% PEI.
Analytical Performance of the Multi-Flask System. Evaluation of the system and separation chemistry 
was performed at the intermediate level, sampling from a single flask of culture media over 4 days. The peak area 
for lactate was corrected using that of the chloride peak as internal standard to eliminate any variation resulting 
from changes in injection volume. The repeatability of the separation is depicted in Fig. 2A with the correspond-
ing electropherogram given in Fig. 2B. The method was validated, with precision of the corrected migration times 
of 0.71% RSD (n = 5) and 0.26% RSD (n = 5) for interday and intraday respectively. The precision in normalized 
peak area was 7.88% RSD (n = 5) and 5.97% RSD (n = 5) for interday and intraday, respectively. The system was 
calibrated by using standards containing 0.15, 0.45, 1.35, 4.00, 8.00 and 15.00 mM lactate in RPMI-1460 media 
with 10% FCS, corrected for chloride as internal standard. Based on 5 injections at each concentration, the detec-
tor response was determined to linear from 0.15–15 mM (y = 28.992x + 14.735, r2 = 0.9931). The LOD for lactate 
was 9 µM with a LOQ of 17 µM (determined using S/N = 5 and S/N = 3, respectively).
To assess the ruggedness of the analysis from the five flasks, the same culture media (without cells) was dis-
tributed across five flasks. The system sampled hourly from each of these 5 flasks over 4 days. Processing of the 
data indicated a lactate concentration of 1.37 mM. As shown in Fig. 2C, there is an excellent correlation between 
the lactate concentrations in each flask (1.37 mM ± 0.12 in flask 1; 1.37 mM ± 0.12 in flask 2, 1.37 mM ± 0.11 in 
flask 3, 1.38 mM ± 0.12 in flask 4, 1.37 mM ± 0.11 in flask 5) (p = 0.765). The variability in lactate concentration 
between flasks is less than 7.65% across 4 days.
Operational step
Time HV Valves Pump flowrate Consumption
Time 
(s)
HV 
supply
Selector 
valve 
position
Switching 
valve 
position
3-way 
solenoid to
2-way 
solenoid 
position
BGE (µL.
min−1)
Sample + carrier 
(µL.min−1)
BGE 
(µL)
Sample 
(µL)
Carrier 
(µL)
1 Separation & Sampling 452 On 2 1 Waste Open 50 8 376.7 60.25 0
2 Capillary flushing, sample to H-filter 115 Off 1 1 Waste Closed 250 90 479.2 0 172.5
3 Equilibrate 2 Off 1 1 Waste Open 0 0 0 0 0
4 Extraction (H-filter) 60 Off 1 1 Waste Open 50 8 50 0 8
5 Fill T-interface with sample 78 Off 1 2 Interface Open 0 180 0 0 234
6 Hydrodynamic injection 1 Off 1 2 Interface Closed 0 10 0 0 0.2
7 Fill T-interface with BGE 12 Off 1 1 Waste Open 250 8 50 0 1.6
TOTAL 720 955.9 60.25 416.3
Table 1. Sequence of events and volumes of BGE, sample and sample carrier solution used by the SI-CE system.
Figure 2. (A) Repeatability in the detection of analytical targets in RPMI-1640 cell culture media with 10% 
FCS (without cells) in one flask over continuous 4 days, (B) corresponding electropherogram showing chloride, 
nitrate, carbonate, lactate, and amino acids glutamine and leucine/isoleucine. Conditions: 80 cm × 50 μm I.D. 
× 350 μm O.D. fused silica capillary coated with HDMB/PSS/HDMB; BGE: 35 mM Tris/35 mM CHES, pH 8.9 
with 0.025% PEI; +28 kV, C: Repeatability of lactate concentrations in RPMI-1640 cell culture media with 10% 
FCS (without cells) in five flasks over continuous 4 days.
www.nature.com/scientificreports/
4SCientiFiC REPORTS | 7: 10337  | DOI:10.1038/s41598-017-10472-1
Because the drugs selected for this study were selected because of their reported effect of on extracellular lac-
tate concentration, all data analysis reported here focuses on lactate. For glutamine and leucine/isoleucine, similar 
profiles are expected, demonstrating the richness of the data that can be obtained using this method. To account 
for the lactate present at t = 0 s, the metabolic activity in this paper is described as a change in lactate concentra-
tion (Δlactate), not in absolute lactate concentration.
Simultaneous Monitoring of Five Parallel Cell Cultures. Biological systems are dynamic systems 
where the metabolic behavior should be repeatable when the culture conditions are precisely controlled. To study 
the biological variability, 5 parallel cell culture flasks from a common culture of T-lymphocyte cell line (Jurkat) 
were cultured under identical conditions. Following the protocol described in Table 1, a cell-free sample was 
analyzed every 12 min; one per bioreactor per hour. It is important to note that the cells were removed without 
lysis, hence the sample only contained media and extracellular compounds. To correlate Δlactate with cell density 
over 96 hr, a total of 480 electropherograms and 480 images were analysed: 96 electropherograms and 96 images 
for each culture flask. Each analysis required 60.25 µL of culture media, hence 5.78 mL of media per flask was used 
for analysis over four days, which is less than 10% of the initial media volume. For the 5 parallel cultures Δlactate 
showed good similarity over the culture period over 4 days (Fig. 3A), with a combined variability of 12.05%. The 
cell growth, measured by the increase in cell density over time, also showed excellent similarity across the five 
flasks (Fig. 3B). As illustrated in Fig. 3C, the variability in the Δlactate per cell was also low. The high level of simi-
larity obtained analyzing the data obtained for 5 cultures in parallel provided the confidence that the developed 
system could be applied to study the effect of pharmaceutically active compounds known to influence lactate pro-
duction. Additionally, combining the variability of 12.5% in presence of cells with the 7.65% analytical variability 
reported in Fig. 2 provides a unique insight in the biological variability introduced by the cells. Sealing of the 
Tygon tubing in the coverlids with silicone was critical to keeping the cultures infection-free, with the incidence 
of infection/contamination less than 1 in 15 flasks.
Pharmacological Applications. Lactate is considered as one of the most important biomarkers of metab-
olism and energy status in mammalian cell culture20. Normally, lactate is produced from glucose and glutamine 
in mammalian cells as a result of their conversion into ATP21. Lactate levels are inversely correlated to mitochon-
drial function, as impaired mitochondrial function will enhance glycolysis to meet the cells energy needs. This in 
turn relies on the conversion of pyruvate into lactate to generate nicotinamide dinucleotide NAD+ required for 
glycolysis. Mitochondrial impairment has been demonstrated to increase lactate production in Jurkat cells22, 23, 
whereas, enhancing mitochondrial oxidative phosphorylation has been demonstrated to decrease lactate produc-
tion in tumor cells24. Three drugs with reported metabolic effects were selected to demonstrate the SI-CE system 
for monitoring parallel suspension cultures. The way these drugs are thought to affect mitochondrial function is 
depicted in a simplified schematic in Fig. 4.
A Mitochondrial Inhibitor – Rotenone. Rotenone is utilized as an insecticide and its toxicity is based 
on inhibiting mitochondrial respiration25. Rotenone is a high affinity mitochondrial NADH dehydrogenase 
(complex I) inhibitor, which at nM concentrations increases extracellular lactate levels26. Complex 1 is essential 
for mitochondrial oxidative phosphorylation27. Preliminary cell toxicity testing (data not shown) indicated a 
non-toxic concentration below 10 nM, hence it was decided to test the SI-CE system for monitoring bioreactors 
with 1 nM, 6 nM and 10 nM rotenone in parallel with two control experiments in the remaining two flasks. The 
data are summarized as Δlactate per cell in Fig. 5, with underlying experimental data given in the Supplementary 
Information. The non-corrected data in SI Figure 1A indicate 1 nM and 6 nM rotenone increased lactate produc-
tion, whereas treatment with 10 nM rotenone decreased lactate production in comparison with the control flasks, 
a trend that is inconsistent with its known pharmacological behavior. However, rotenone is also known to be 
cytotoxic and can cause cellular death28. The cell density profiles (Fig. SI–1B) confirm a dose- and time-dependent 
reduction in cell growth compared to controls. The standardized results (Fig. SI–1C) agree with the established 
pharmacological behavior and demonstrate increased lactate production. This confirms our earlier conclusion 
Figure 3. Simultaneous monitoring of 5 parallel cell cultures of Jurkat cells over 4 days. (A) Changes in lactate 
concentration determined using the conditions detailed in Fig. 2, (B) Changes in cell density, (C) Lactate 
concentrations standardized on cell density. No significant differences were found between the 5 parallel 
cultures based on the rate of lactate production per cell per time, (p values range 0.072–0.791), using one way 
ANOVA test.
www.nature.com/scientificreports/
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that it is important to correct Δlactate for cell density17. The standardized lactate production is plotted against the 
variables rotenone concentration and time in a 3D surface plot in Fig. 5A. Treatment with 1 nM rotenone showed 
no measurable difference in Δlactate, suggesting this concentration was below the effective inhibitory concentra-
tion. The end-point measurement at 96 hr indicates only lactate production from the 10 nM rotenone treatment 
was distinctly different from the control and other concentrations (p < 0.001). When considering the time-based 
profiles, however, we find that the rate of lactate production per cell differed across the rotenone concentrations 
over the first 20 hr. For the 10 nM treatment, lactate was produced at 0.44 fmole/(cell.hr) which is significantly 
different from the control (p = 0.002). For the flask using 6 nM rotenone, this was 0.31 fmole/(cell.hr), also signifi-
cantly different from the control (p = 0.029). For the 1 nM, the measured 0.20 fmole/(cell.hr) was not significantly 
different from the control 0.24 fmole/(cell.hr) (p = 0.149). From Fig. 5A we can conclude that after about 20 hr, 
the cell metabolism switched from lactate production to lactate consumption as evidenced by the decrease and 
stabilization of the amount of lactate produced per cell. At this stage, the effect of rotenone is no longer noticeable 
on Δlactate per cell.
A Mitochondrial Toxin – Clioquinol. Clioquinol (CQ) has been clinically used as an antibiotic and anti-
fungal agent29 before it was removed from the market due to neurotoxicity that was likely related to impaired 
mitochondrial function30. CQ indirectly induces mitochondrial dysfunction by increasing oxidative stress and 
lipid peroxidation (Fig. 4). However, the cellular response to compensate for reduced mitochondrial ATP synthe-
sis increases glycolysis, similar to the metabolic effect of rotenone. Therefore, CQ treatment of cells was expected 
to increase lactate production like rotenone. CQ was added to three parallel cultures at 1 µM, 5 µM and 10 µM, 
respectively, and together with two controls, these five flasks were monitored simultaneously under identical con-
ditions. Looking at the raw data, lactate production (Fig. SI-1D) in controls and 1 µM CQ was similar (p = 0.971), 
and an unexpected decrease in lactate production was observed for 5 µM and 10 µM CQ. This decrease in lac-
tate production coincided with a dose-dependent reduction in cell density compared to the control cultures (SI 
Fig. 1E).
Considering Δlactate per cell (Figure SI-F), a dose-dependent increase in lactate production is observed. The 
3D surface visualizes the dose-dependent effect of CQ on Δlactate per cell over time (Fig. 5). The increase in lactate 
production indicates that CQ decreased the metabolic activity of Jurkat cells by impairing their mitochondrial 
function. In this case, the valuable information added by monitoring the culture rather than relying on end-point 
Figure 4. Schematic explanation of lactate production in cells because of the generation of NAD+ from NADH 
to sustain glycolysis. Rotenone is a mitochondrial poison, inhibiting mitochondrial function; cloquinol causes 
oxidative stress and as a result compromises mitochondrial function and β lapachone results an increase of 
NAD+, which is believed to reduce the need for lactate production.
Figure 5. 3D surface diagrams graphically illustrating the relationship between lactate production per cell and 
drug concentration over 96 hr for (A). Rotenone, (B). Clioquinol and (C). β-lapachone. The change in lactate 
was determined by SI-CE using the conditions described in Fig. 2 and corrected for cell density.
www.nature.com/scientificreports/
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measurements is that while the lactate production rate is the same for the treated and control experiments, a 
correlation between the duration of the lactate producing phase and CQ concentration can be observed. This 
may be explained by the fact the rate at which cells change from lactate production to lactate consumption may 
be influenced by oxidative stress. The apparent increase in Δlactate per cell between 45 and 75 hr for the 10 µM CQ 
treated culture is most likely the result of increased imprecision caused by decreased reliability of the cell density 
measurements at the low cell density resulting from CQ toxicity (Fig. SI-1E).
A Mitochondrial Activated Cytotoxin – β-lapachone. β-lapachone, a naphthoquinone deriva-
tive, increases the intracellular NAD+/NADH ratio by enabling the NQO1-dependent oxidation of NADH to 
NAD+31. Jeong et al. reported a reduction in lactate production by 1 µM β-lapachone in two hybrid cell lines32. 
The reason for this reduced lactate production is thought to be partially a consequence of increased NAD+ lev-
els by β-lapachone, alleviating the need for NAD+ production through the conversion of pyruvate into lactate 
(Fig. 4). The previously reported β-lapachone concentration (1 µM) resulted in significant cytotoxicity in our cell 
line, with normal cell growth only observed at 0.2 µM or below. Therefore, monitoring experiments were con-
ducted with β-lapachone at 50 nM, 100 nM and 200 nM, again combined with two parallel controls. In the raw 
data, the only significant difference in Δlactate was found between 0.1 µM treatment and control (p = 0.015) (Fig. 
SI-1G). No dose-dependent effects were observed on cell density (Fig. SI-1H). No statistically significant differ-
ences in Δlactate standardized by cell density were observed between the rate of lactate production per cell between 
50 nM and control (p = 0.714) (Fig. SI-1I), between 100 nM and control (p = 0.7644) and between 200 nM and 
control (p = 0.145), using a one-way ANOVA test. The surface plot derived from the standardized lactate pro-
duction for the different concentrations over time confirms there are no dose-related effects on Δlactate per cell 
for β-lapachone over the 4 days (Fig. 5C). This suggests β-lapachone does not affect Δlactate per cell. Considering 
the toxicity of β-lapachone, the previously reported decrease in lactate production may have been the result of a 
decrease in cell density rather than an actual effect on lactate production32. This again demonstrates the value of 
our system by being able to provide the data required to standardize on cell number for metabolite measurements 
over time.
From these tests, we can conclude that the SI-CI system for monitoring 5 parallel suspension cultures is suit-
able for conducting parallel, time resolved cell assays over at least 96 hr. The time-dependent profile provides 
deeper insight in the pharmacodynamics of the administered compound, especially when these effects vary over 
time. 3D surface plots provide a means to visualize the times of lowest and highest response for a specific drug 
and dosage. The temporal insight provided by the presented method is unique and provides a better understand-
ing of the underlying metabolic effects.
When comparing the three surface plots, the control profiles (no drug added) vary for the three different 
experiments. Based on the excellent agreement documented for the five parallel cultures in Fig. 3, these differ-
ences are most likely the result of a difference in metabolic starting point between these three experiments. This 
again emphasizes the importance of having parallel controls analysed with the drug studies to be able to delineate 
pharmacological effects from effects related the metabolic starting point. Recognizing the current approach only 
determines extracellular lactate, further studies are required to determine intracellular effects. Based on the pre-
sented data, it appears the differences in Δlactate per cell over time may be indicative of the different pharmacology 
of rotenone and clioquinol.
Conclusion
A fully automated system for monitoring extracellular media for five parallel suspension cultures was devel-
oped and applied to study the effects of three different pharmaceutically active compounds. Combining a 
high-resolution separation with cell density measurement, a SI-CE system was integrated with microfluidic 
units for cell counting and the extraction of analytes into a cell-free sample. Streamlining of the fluidic opera-
tions allowed for a run-to-run time of 12 min, enabling an analysis per hour for each of the five culture flasks. 
Combined with low sample consumption (60 µL/analysis) and high throughput (480 analyses in 4 days), this 
system provides a new approach to study time-resolved pharmacological and metabolic effects in in-vitro assays. 
The system was applied to monitoring lactate, with the interday precision of the electrophoretic mobility and 
peak area 1.35% RSD and 8.11% RSD respectively. A good correlation was obtained for cell density and lactate 
measurements across identical parallel cultures (p = 0.765). When applied to a pharmacological assay for rote-
none, clioquinol and β-lapachone, concentration-dependent increases in the production of lactate was observed 
for rotenone and clioquinol, with their pharmacological differences reflected in changes in the rate of lactate 
production over time. For rotenone, a steep increase was observed over the first 20 hr, whereas for cliquinol the 
pharmacological effect was most noticeable over the 20–96 hr interval. This difference may have gone unnoticed 
when solely relying on end-point measurements. After correction for cell density, no concentration effect on 
lactate production could be identified for β-lapachone, suggesting earlier reports of decreased lactate production 
may have been the result of toxicity causing cell death.
With the target analytes defined by the separation chemistry, the proposed system provides a flexible platform, 
where other targets can be accommodated for changing the separation chemistry, with no or minimal changes to 
the hardware. Integration of the cell count and H-filter devices, as well as further miniaturization of the system 
would lead to increased throughput and simplify the setup, while the reduction in dead volume would further 
reduce sample consumption.
Methods
Chemicals and Reagents. All chemicals were obtained as analytical grade reagent from Sigma–Aldrich, 
(Sydney, Australia) and used as provided unless indicated otherwise. All solutions were prepared in Milli-Q 
water (Millipore, Bedford, MA, USA) and micro-filtered prior usage. 20 mM lactate, 10 mM L-glutamine, 5 mM 
www.nature.com/scientificreports/
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L-leucine, 5 mM L-isoleucine, 5 mM L-arginine and 2 M chloride standard solution were prepared and stored 
at 8 °C. Rotenone, β-lapachone and clioquinol (Ciba chemicals, Basel, Switzerland) were all prepared at 10 mM 
and frozen before dilution and addition to culture media. The cationic polyelectrolyte poly(ethylenimine) (PEI) 
(ACROS organics, Geel, Belgium) at 0.025% was added to BGE. An 80 cm polyelectrolyte coated fused-silica cap-
illary was prepared by flushing the capillary with hexadimethrine bromide (HDMB) and poly(sodium 4-styrene 
sulfonate homopolymer) (PSS) and (HDMB) to reverse the EOF. The BGE consisted of a combination of tris(hy-
droxymethyl) aminomethane (Tris)) and N-cyclohexyl-2-aminoethanesulfonic acid (CHES) at pH 8.9.
Instrument Design. The SI-CE instrumentation was modified from a design developed earlier in our labo-
ratory15. It consists of two peristaltic pumps (PeriWaves, CorSolutions, Ithaca, NY, USA) for sample introduction 
and BGE delivery. In comparison with the previous system, a 7-port selector valve (MXP-7970, Rheodyne, Oak 
Harbor, WA, USA) was added to enable sequential sampling from the five culture flasks. A microfluidic chamber 
was employed to determine the cell density, an H-filter to prevent cells and debris from clogging the injector 
valve. A three-way solenoid valve (360T041SHH, NResearch, West Caldwell, NJ, USA) was used to control flow 
of either the extracted sample or the carrier solution into the injector. A high-pressure two-position six port 
switching valve (MXP9900-000, Rheodyne, Oak Harbor, WA, U.S.A) was used to deliver either BGE or sample 
to the capillary interface. A PEEK T-piece-connector (P-727, Upchurch Scientific, OakHarbor, WA, U.S.A.) was 
used to interface the flow injection system with the separation capillary. A fused silica capillary (50 μm I.D.; 
Polymicro Technologies, Phoenix, AZ, USA) was used for separation and its inlet was positioned in the interface 
to eliminate any carry over, with the outlet immersed in a glass vial filled with 25 mL BGE. A 20 mm long stainless 
steel syringe needle was used to connect the T-interface with Teflon tubing (1.6 mm O.D., 0.5 mm I.D.) and used 
as a hollow electrode. A two-way solenoid valve (HP225K021, NResearch, West Caldwell, NJ, USA) was used to 
stop the flow between the separation capillary and the waste to perform a hydrodynamic injection. Detection was 
realized using a capacitively coupled contactless conductivity detection (C4D) (Tracedec, Istech GmbH, Strasshof, 
Austria) with optimized operational parameters as follows: frequency, 2x high; voltage, 18 Db; gain, 200%; off set, 
000. A high-voltage power supply (4300 Emco, Sydney, NSW, Australia) with positive polarity was connected to 
the anode immersed in the outlet BGE vial. A NI USB-6212 data acquisition interface board (National instru-
ments, Austin, TX, U.S.A.) using LabView v8.1 (National Instruments) was used to control the peristaltic pumps, 
selector and solenoid valves and power supply, and for collection and saving the data.
Cell Density Measurement. A microscopy chamber (1 μ-slideVI0.1, Ibidi GmbH, Martinsried, Germany) 
prepared as described previously was placed on the stage of a phase contrast microscope connected to a digital 
camera (AM7023B Dino-Eye, New Taipei City, 241 Taiwan) to count cells by image capture. Images were auto-
matically captured at 40x magnification every 12 minutes as programmed to correlate with sample injection into 
the SI-CE. Images were analyzed to determine % surface area covered by cells or aggregates using the freeware 
package Image J to determine the cell density. Reproducibility and validation of this procedure are discussed 
elsewhere17.
H-Filter. An H-filter with a 40 mm long, 1 mm wide and 0.285 mm high central channel was made by soft 
lithography in PDMS using a dry film photoresist template (EP SUEX TDFS Sudbury, MA, USA) created using 
a laser printed transparency mask17, 33. The H-filter was employed to acquire a cell- and particulate-free solution 
with at least 30% of the target analytes in the acceptor stream at a flow rate of 8 μL.min−1. Design, fabrication, 
validation and extraction efficiency are described in detail in our previous work17.
Instrument Operation. The SI-CE setup is schematically depicted in Fig. 1 and was operated in 7 consecu-
tive steps. The 7-port selector valve was switched to withdraw sample from the first culture flask at the lowest flow 
rate to enable the image capture of the cells inside the counting device while the three-way solenoid was switched 
to flush the rest of previous sample to the waste.
Simultaneously, the switching valve was switched back to direct BGE towards the T-interface at low flow rate 
while the two-way solenoid was open, and the high voltage (HV, + 28 kV) was applied on the capillary for the 
electrophoretic separation of the previous sample. The selector valve was switched back to withdraw the sample 
carrier solution at higher flow rate to carry the sample through the sample peristaltic pump into the H-filter. At 
the same time, the two-way solenoid was closed and both the T-interface and capillary were filled and flushed 
with BGE at higher flow rate to equilibrate the separation capillary, remove any air bubbles or partial blockage 
and stabilize the baseline. The sample flow rate was lowered back to 8 µL.min−1 to enable the diffusion of tar-
get analytes away from the cells in the donor into an acceptor solution in the H-filter. In parallel, the two-way 
solenoid was reopened and the flow of BGE reduced to eliminate the pressure in the T-interface. The three-way 
solenoid was switched to transport the cell-free media into the switching valve at higher flow rate. The switching 
valve was switched to direct sample to the T-interface and the two-opening solenoid valve was closed for one sec-
ond to hydrodynamically inject the sample plug into the separation capillary. In the final stage of this run, small 
amount of the carrier solution was withdrawn to initiate the sample pump for the next run. And in the meantime, 
the switching valve was switched to deliver BGE to clean the T-interface from the rest of the sample at a higher 
flow rate, and to prepare the setup to begin the next run. Events sequence, conditions and liquids volumes were 
cautiously optimized and are detailed in Table 1. All separations were performed at room temperature (20 °C).
Electrophoretic Conditions. Separations were performed using fused-silica capillaries (50 µm I.D., 
360 µm O.D. and 80 cm in length, LD = 70 cm). Capillaries were conditioned by flushing with 1 M NaOH at 0.5 µL.
min−1 for 10 min then Milli-Q water at the same rate for 5 min. For polyelectrolyte coating, the capillary was 
flushed with 1% aqueous solution of HDMB for 10 min at 0.5 µL.min−1, Milli-Q water at the same rate for 5 min, 
1% PSS for 10 min at 0.5 µL.min−1, Milli-Q water at the same rate for 5 min, 1% aqueous solution of HDMB for 
www.nature.com/scientificreports/
8SCientiFiC REPORTS | 7: 10337  | DOI:10.1038/s41598-017-10472-1
10 min at 0.5 µL.min−1 and finally with BGE for at least 30 min. The optimized BGE consisted of 35 mM of Tris 
(tris(hydroxymethyl)-aminomethane) and 35 mM CHES (cyclohexyl-2-aminoethanesulfonic acid) at pH 8.86. 
0.025% (w/v) PEI was added for coating stabilization and selectivity alteration. Electrophoretic separations were 
conducted at 28 kV. A nitrogen gas line was connected to the BGE bottle to prevent change of the pH from the 
absorption of CO2.
Cell Culture. The human T lymphocyte cell line (Jurkat ATCC® TIB-152) was cultured in T75 cell culture 
flask (Corning® 75 cm2 rectangular canted neck cell culture flask with vented cap) routinely at 37 °C and 5% 
CO2 in a cell culture incubator, in RPMI-1640 Medium (23.8 mM NaHCO2, L-glutamine without HEPES; 10% 
fetal calf serum; FCS, VWR, Murarrie, Australia). For the assays, 225 million cells were centrifuged at 200 g for 
5 minutes at room temperature. Pellets were re-suspended gently in 200 mL culture medium and transferred into 
a 500 mL Erlenmeyer flask to form a total volume of 300 mL, equivalent to 7.5 × 105 cells.mL−1. This 300 mL was 
distributed equally over 5 Pyrex® 250 mL Erlenmeyer flasks with screw cap (4985, Fisher Scientific, USA), adding 
60 mL to each. These flasks were positioned and fixed in an orbital shaking water bath (OW1412, Paton Scientific, 
Victor Harbor, SA, Australia) at 37 °C and at 100 rpm. Water covered entire flasks to the neck to maintain a con-
stant temperature through culturing time. The coverlid of each flask was drilled with a 0.95 mm diameter hole 
to insert (0.91 mm O.D., 0.19 mm I.D) Tygon tubing (SC0001T, ISMATEC, Wertheim, Germany) for sampling. 
All five tubing sections were connected to five inlet ports of the selector valve at positions (no. 2 to 6). Position 
no.1 was connected to a carrier solution (5% methanol solution). A (0.91 mm O.D., 0.25 mm I.D) Tygon tubing 
(SC0002, ISMATEC, Wertheim, Germany) was connected to the selector valve outlet (position 7) and to the inlet 
of a counting chamber positioned on a microscope connected to a digital camera (AM7023B Dino-Eye, New 
Taipei City, 241 Taiwan) for image capturing for cell density determinations. The sample peristaltic pump was 
connected to the outlet of the counting chamber. As careful sterility guarantee is very important to ensure repro-
ducible and accurate outcomes the culture flasks, Tygon tubing with coverlids, peristaltic pump tubing and the 
H-filter were autoclaved prior their use. The whole setup was fitted in a laminar flow cabinet (ESCO, Singapore) to 
diminish the risk of contamination. Serial dilutions with media were performed to realize the indicated concen-
trations of respectively clioquinol, β-lapachone and rotenone in the culture flasks, concentrations are reported as 
final concentrations during the experiment.
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